The association between anthropometric indicators of obesity and cardiac reverse remodelling with empagliflozin in patients with type 2 diabetes and coronary artery disease-Reference-Cited by-同舟云学术

The association between anthropometric indicators of obesity and cardiac reverse remodelling with empagliflozin in patients with type 2 diabetes and coronary artery disease

Published:2023-05-29 Issue:9 Volume:25 Page:2765-2769
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Puar Pankaj¹²³,Ahmed Shamon³,Hibino Makoto⁴^ORCID,Pasricha Aryan⁵,Pandey Arjun⁶,Bari Amaan¹,Verma Raj⁷,Quan Adrian¹²^ORCID,Yan Andrew T.²⁸⁹^ORCID,Connelly Kim A.²⁸⁹¹⁰^ORCID,Teoh Hwee¹²¹¹^ORCID,Mazer C. David²¹⁰¹²¹³¹⁴^ORCID,Verma Subodh¹²¹⁴¹⁵^ORCID

Affiliation:

1. Division of Cardiac Surgery St Michael's Hospital of Unity Health Toronto Toronto Ontario Canada

2. Li Ka Shing Knowledge Institute of St Michael's Hospital Toronto Ontario Canada

3. Faculty of Medicine University of British Columbia Vancouver British Columbia Canada

4. Division of Cardiothoracic Surgery Emory University School of Medicine Atlanta Georgia USA

5. Wake Forest University Winston‐Salem North Carolina United States

6. Michael G. DeGroote School of Medicine McMaster University Hamilton Ontario Canada

7. School of Medicine Royal College of Surgeons in Ireland Dublin Ireland

8. Division of Cardiology St Michael's Hospital of Unity Health Toronto Toronto Ontario Canada

9. Department of Medicine University of Toronto Toronto Ontario Canada

10. Department of Physiology University of Toronto Toronto Ontario Canada

11. Division of Endocrinology and Metabolism St Michael's Hospital of Unity Health Toronto Toronto Ontario Canada

12. Department of Anaesthesia St Michael's Hospital of Unity Health Toronto Toronto Ontario Canada

13. Department of Anaesthesiology and Pain Medicine University of Toronto Toronto Ontario Canada

14. Department of Pharmacology and Toxicology University of Toronto Toronto Ontario Canada

15. Department of Surgery University of Toronto Toronto Ontario Canada

Funder

Boehringer Ingelheim

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference13 articles.

1. Overweight and Obesity as Determinants of Cardiovascular Risk

2. Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity

3. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association

4. Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study

5. Efficacy of dapagliflozin in heart failure with reduced ejection fraction according to body mass index